Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Pfizer Beats Consumer Suit Over Recalled Smoking Cessation Drug

Feb. 17, 2022, 8:13 PM

Pfizer Inc. shook off a suit by smokers who alleged it deceived them about Chantix that was recalled because of a cancer-causing substance, as a federal court in New York said the consumers didn’t show that it made false statements concerning the smoking-cessation drug.

Roslyn Harris and Mary Allen sued Pfizer in August 2021. The proposed class action followed the company’s voluntary recall of Chantix found to be contaminated with excess levels of N-nitroso-varenicline, a nitrosamine compound classified as possibly carcinogenic.

The consumers said they each bought several boxes of Chantix that were subject to recall, but wouldn’t have made ...